169 related articles for article (PubMed ID: 32885525)
1. Low rates of invasive fungal disease in patients with multiple myeloma managed with new generation therapies: Results from a multi-centre cohort study.
Lim C; Sinha P; Harrison SJ; Quach H; Slavin MA; Teh BW
Mycoses; 2021 Jan; 64(1):30-34. PubMed ID: 32885525
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.
Liu J; Huang H; Li Y; Liu L; Li J; Liu Z; Lu J; Ouyang J; Song Y; Zhou D; Ren H; Ma J; Wang C; Yu L; Zhou J; Wang J; Xiao Y; Huang X; Li J
Tumour Biol; 2016 Jun; 37(6):7893-900. PubMed ID: 26700667
[TBL] [Abstract][Full Text] [Related]
3. Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies.
Deng Q; Lv HR; Lin XM; Zhao MF; Geng L; Li YM
Curr Med Res Opin; 2018 Jul; 34(7):1209-1216. PubMed ID: 28956459
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant.
Zhang X; Zhang L; Li Y; Wang N; Zhang Y
Front Cell Infect Microbiol; 2024; 14():1210857. PubMed ID: 38590441
[TBL] [Abstract][Full Text] [Related]
5. Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?
Marchesi F; Pimpinelli F; Di Domenico EG; Renzi D; Gallo MT; Regazzo G; Rizzo MG; Gumenyuk S; Toma L; Marino M; Cordone I; Cantonetti M; Liberati AM; Montanaro M; Ceribelli A; Prignano G; Palombi F; Romano A; Papa E; Pisani F; Spadea A; Arcese W; Ensoli F; Mengarelli A
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893777
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
7. Intravenous and tablet formulation of posaconazole in antifungal therapy and prophylaxis: A retrospective, non-interventional, multicenter analysis of hematological patients treated in tertiary-care hospitals.
Heimann SM; Penack O; Heinz WJ; Rachow T; Egerer G; Kessel J; Claßen AY; Vehreschild JJ
Int J Infect Dis; 2019 Jun; 83():130-138. PubMed ID: 30978465
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review.
Yeoh DK; Moore AS; Kotecha RS; Bartlett AW; Ryan AL; Cann MP; McMullan BJ; Thursky K; Slavin M; Blyth CC; Haeusler GM; Clark JE
Pediatr Blood Cancer; 2021 Nov; 68(11):e29275. PubMed ID: 34357688
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
Lum L; Lee A; Vu M; Strasser S; Davis R
Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
[TBL] [Abstract][Full Text] [Related]
10. Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
Wang L; Wang Y; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
Front Med; 2019 Jun; 13(3):365-377. PubMed ID: 30604166
[TBL] [Abstract][Full Text] [Related]
11. Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation.
Ceesay MM; Kordasti S; Rufaie E; Lea N; Smith M; Wade J; Douiri A; Mufti GJ; Pagliuca A
J Infect; 2016 Sep; 73(3):280-8. PubMed ID: 27343564
[TBL] [Abstract][Full Text] [Related]
12. [A clinical study of invasive fungal disease in children without underlying diseases].
Li WR; Deng SY; Shu M; Zhu Y; Wen Y; Guo Q; Liao Q; Wan CM
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Aug; 18(8):713-7. PubMed ID: 27530787
[TBL] [Abstract][Full Text] [Related]
13. Impact of neutropenia evaluated in terms of the D-index on invasive fungal disease while on empiric or preemptive antifungal treatment strategy in the early phase after allogeneic hematopoietic stem cell transplantation.
Kimura SI; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Yoshino N; Misaki Y; Yoshimura K; Matsumi S; Gomyo A; Akahoshi Y; Tamaki M; Kusuda M; Kameda K; Wada H; Sato M; Terasako-Saito K; Tanihara A; Nakasone H; Kako S; Kanda Y
Transpl Infect Dis; 2020 Dec; 22(6):e13409. PubMed ID: 32654234
[TBL] [Abstract][Full Text] [Related]
14. Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections.
Calle-Miguel L; Garrido-Colino C; Santiago-García B; Moreno Santos MP; Gonzalo Pascual H; Ponce Salas B; Beléndez Bieler C; Navarro Gómez M; Guinea Ortega J; Rincón-López EM
BMC Infect Dis; 2023 May; 23(1):348. PubMed ID: 37226103
[TBL] [Abstract][Full Text] [Related]
15. Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study.
Ruchlemer R; Ben-Ami R; Bar-Meir M; Brown JR; Malphettes M; Mous R; Tonino SH; Soussain C; Barzic N; Messina JA; Jain P; Cohen R; Hill B; Mulligan SP; Nijland M; Herishanu Y; Benjamini O; Tadmor T; Okamoto K; Arthurs B; Gottesman B; Kater AP; Talha M; Eichhorst B; Korem M; Bogot N; De Boer F; Rowe JM; Lachish T
Mycoses; 2019 Dec; 62(12):1140-1147. PubMed ID: 31520441
[TBL] [Abstract][Full Text] [Related]
16. Clinical features in proven and probable invasive fungal disease in children and adolescents at a pediatric referral center: a 5-year experience.
Kishimoto K; Kasai M; Kawamura N; Ito Y; Yoshida M; Hasegawa D; Kawasaki K; Kosaka Y
World J Pediatr; 2019 Jun; 15(3):270-275. PubMed ID: 31011987
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
[TBL] [Abstract][Full Text] [Related]
18. Clinical study on empirical and diagnostic-driven (pre-emptive) therapy of voriconazole in severe aplastic anaemia patients with invasive fungal disease after intensive immunosuppressive therapy.
Wu Y; Yan L; Wang H; Liu H; Xing L; Fu R; Shao Z
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):949-954. PubMed ID: 33219473
[TBL] [Abstract][Full Text] [Related]
19. Invasive Fungal Disease in Critically Ill Patients at High Risk: Usefulness of Lymphocyte Subtyping.
Zhang J; Cui N; Wang H; Han W; Li Y; Xiao M; Liu D
J Intensive Care Med; 2020 Sep; 35(9):909-918. PubMed ID: 30231674
[TBL] [Abstract][Full Text] [Related]
20. Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network.
Galmiche S; Thoreau B; Bretagne S; Alanio A; Paugam A; Letscher-Bru V; Cassaing S; Gangneux JP; Guegan H; Favennec L; Minoza A; Morio F; Bonhomme J; Desoubeaux G; Eloy O; Hasseine L; Sasso M; Millon L; Bellanger AP; Poirier P; Moniot M; Chouaki T; Huguenin A; Dalle F; Bouteille B; Nicolas M; Desbois-Nogard N; Bougnoux ME; Danion F; Poindron V; Néel A; Boukris-Sitbon K; Lanternier F; Terrier B;
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37558492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
